AC Immune

$6.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.33 (-4.67%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AC Immune and other stocks, options, and ETFs commission-free!

About ACIU

AC Immune SA engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.

CEO

Andrea Pfeifer

Employees

149

Headquarters

Lausanne, Vaud

Founded

2003

Market Cap

462.25M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

182.48K

High Today

$7.04

Low Today

$6.70

Open Price

$7.04

Volume

131.04K

52 Week High

$13.00

52 Week Low

$4.42

ACIU Earnings

-$0.28

-$0.10

$0.08

$0.26

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Available Apr 28, Pre-Market